GE HealthCare Technologies Inc. $GEHC Shares Sold by Van ECK Associates Corp

Van ECK Associates Corp trimmed its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 2.3% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 4,392,626 shares of the company’s stock after selling 105,201 shares during the period. Van ECK Associates Corp’s holdings in GE HealthCare Technologies were worth $360,283,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently modified their holdings of the business. Vanguard Group Inc. raised its holdings in shares of GE HealthCare Technologies by 0.5% during the fourth quarter. Vanguard Group Inc. now owns 52,275,767 shares of the company’s stock worth $4,287,658,000 after purchasing an additional 267,058 shares during the period. Dodge & Cox grew its position in shares of GE HealthCare Technologies by 16.8% during the third quarter. Dodge & Cox now owns 27,517,311 shares of the company’s stock worth $2,066,550,000 after acquiring an additional 3,949,361 shares during the last quarter. Capital Research Global Investors grew its position in shares of GE HealthCare Technologies by 1.6% during the fourth quarter. Capital Research Global Investors now owns 25,362,352 shares of the company’s stock worth $2,080,248,000 after acquiring an additional 389,796 shares during the last quarter. Geode Capital Management LLC grew its position in shares of GE HealthCare Technologies by 0.3% during the fourth quarter. Geode Capital Management LLC now owns 12,112,503 shares of the company’s stock worth $989,673,000 after acquiring an additional 37,159 shares during the last quarter. Finally, Hotchkis & Wiley Capital Management LLC grew its position in shares of GE HealthCare Technologies by 17.1% during the third quarter. Hotchkis & Wiley Capital Management LLC now owns 8,432,374 shares of the company’s stock worth $633,271,000 after acquiring an additional 1,232,828 shares during the last quarter. 82.06% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other GE HealthCare Technologies news, Director Kevin Lobo purchased 10,000 shares of the business’s stock in a transaction on Friday, May 22nd. The stock was bought at an average cost of $64.18 per share, with a total value of $641,800.00. Following the acquisition, the director owned 14,363 shares of the company’s stock, valued at $921,817.34. The trade was a 229.20% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Rodney F. Hochman purchased 1,618 shares of the business’s stock in a transaction on Tuesday, May 12th. The stock was acquired at an average cost of $62.03 per share, with a total value of $100,364.54. Following the completion of the acquisition, the director directly owned 1,618 shares in the company, valued at $100,364.54. The trade was a ∞ increase in their position. The SEC filing for this purchase provides additional information. Insiders acquired 21,847 shares of company stock worth $1,361,355 in the last ninety days. Insiders own 0.36% of the company’s stock.

GE HealthCare Technologies Stock Performance

Shares of GEHC opened at $65.18 on Friday. The firm has a 50-day moving average price of $66.32 and a 200 day moving average price of $75.20. The firm has a market capitalization of $29.65 billion, a PE ratio of 15.59, a P/E/G ratio of 1.45 and a beta of 0.74. The company has a quick ratio of 0.95, a current ratio of 1.22 and a debt-to-equity ratio of 0.95. GE HealthCare Technologies Inc. has a 52-week low of $58.75 and a 52-week high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). The company had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.04 billion. GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The business’s quarterly revenue was up 7.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.01 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. On average, sell-side analysts anticipate that GE HealthCare Technologies Inc. will post 4.89 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several research firms have recently commented on GEHC. Weiss Ratings lowered shares of GE HealthCare Technologies from a “hold (c)” rating to a “hold (c-)” rating in a research report on Friday, May 15th. Stifel Nicolaus set a $80.00 price target on shares of GE HealthCare Technologies in a research report on Wednesday, April 29th. Wells Fargo & Company lowered their price target on shares of GE HealthCare Technologies from $97.00 to $75.00 and set an “overweight” rating for the company in a research report on Thursday, April 30th. BNP Paribas Exane lowered their price target on shares of GE HealthCare Technologies from $95.00 to $88.00 in a research report on Friday, May 1st. Finally, Citigroup decreased their target price on shares of GE HealthCare Technologies from $80.00 to $65.00 and set a “neutral” rating for the company in a research report on Thursday, April 30th. Nine equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $80.21.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.